Boy’s death fuels family’s mission – The Union Leader
Boy's death fuels family's mission The Union Leader A stem-cell transplant in 2007 saved the child's life, and his story inspired thousands to register as potential donors. Giovanni died at 2:32 am on April 16 — the night of Easter in his mother's Greek Orthodox tradition — after being rushed to a ... |
Obits: Stacy Robinson, Gunnar Soensteby; Carl Beane – Washington Post
Obits: Stacy Robinson, Gunnar Soensteby; Carl Beane Washington Post He underwent chemotherapy, a stem-cell transplant and a bone-marrow transplant provided by his son. He entered hospice care on May 3. The speedy, 5-foot-11 Mr. Robinson played all six of his seasons in the National Football League for the Giants after ... |
Friends come through for ailing Davis artist Gay Powers – Modesto Bee
 Modesto Bee | Friends come through for ailing Davis artist Gay Powers Modesto Bee By Anita Creamer At 66 and desperately ill with the recurrence of an aggressive form of non- Hodgkins lymphoma, Davis artist Gay Powers needed to move closer to the Sutter Cancer Center in Sacramento to prepare for the stem-cell transplant that doctors ... |
New Maintenance Therapy for Multiple Myeloma Looks Promising, Study Suggests – Science Daily (press release)
New Maintenance Therapy for Multiple Myeloma Looks Promising, Study Suggests Science Daily (press release) A medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, is frequently an important treatment option for many patients. Unfortunately, multiple myeloma continues to progress even after a ... |
Study shows benefit of new maintenance therapy for multiple myeloma – Medical Xpress
Study shows benefit of new maintenance therapy for multiple myeloma Medical Xpress A medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, is frequently an important treatment option for many patients. Unfortunately, multiple myeloma continues to progress even after a ... New England Journal of Medicine Reports on Three Phase III REVLIMID(R ... New Drug Shows Promise for Myeloma Patients |
Revlimid Maintenance Therapy: Three Major Studies Clarify The Benefits And Risks – The Myeloma Beacon
Revlimid Maintenance Therapy: Three Major Studies Clarify The Benefits And Risks The Myeloma Beacon In two of the three trials, the initial treatment also included a stem cell transplant. After the initial treatment, patients were randomly assigned to take either Revlimid or a placebo on a regular basis until they relapsed. |
‘Kepler’s Dream,’ by Juliet Bell – New York Times
'Kepler's Dream,' by Juliet Bell New York Times Her mother has leukemia — Extreme Cancer, Ella calls it — and is about to have a stem cell transplant. Her father, who works as a guide at an outdoor travel adventure company, has literally gone fishing, as he has for most of Ella's childhood. |
Compassionate Use of Pluristem’s PLX Cells Saves the Life of a Child after … – Proactive Investors USA & Canada
 OneMedPlace | Compassionate Use of Pluristem's PLX Cells Saves the Life of a Child after ... Proactive Investors USA & Canada “With her body rejecting all possible treatment – and with no other options – we finally turned to Pluristem's PLX cells, which literally saved her life,” said Professor Reuven Or, Director of Bone Marrow Transplantation, Cell Therapy and ... Investors Waking Up To Pluristem's Developments |
Investors Waking Up To Pluristem’s Developments – Seeking Alpha
OneMedPlace | Investors Waking Up To Pluristem's Developments Seeking Alpha Treatment took only two weeks, compared to potential months of bone marrow transplantation. Even more exciting, results point to PLX's effectiveness in treating other disorders that come from low levels of red blood cells. This small patient continues ... Pluristem stem cells save girl's life |
Gene-Modified Stem Cell Transplant Protects Patients from Toxic Side Effects … – Science Daily (press release)
Gene-Modified Stem Cell Transplant Protects Patients from Toxic Side Effects ... Science Daily (press release) As many as 50 percent to 60 percent of glioblastoma patients harbor such chemotherapy-resistant tumors, which makes gene-modified stem cell transplant therapy applicable to a large number of these patients. In addition, there are also other brain ... |